Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion type Assertion NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_head.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion wasGeneratedBy ECO_0000203 NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion wasDerivedFrom befree-2016 NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion SIO_000772 20035824 NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion evidence source_evidence_literature NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.
- NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_assertion description "[CXCR4 inhibition to decrease cell proliferation and to control the leukemic burden may provide a novel therapeutic strategy in patients with advanced FLT3-ITD-positive AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP783761.RAC3qbS-T1Y_rokvZJc5QUERqs1kfOszSNeM8IG6YcrSE130_provenance.